These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8475323)

  • 1. The detection of age-related decrease of dopamine D1, D2 and serotonin 5-HT2 receptors in living human brain.
    Iyo M; Yamasaki T
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 May; 17(3):415-21. PubMed ID: 8475323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of positron emission tomography to measure the effects of nalmefene on D1 and D2 dopamine receptors in rat brain.
    Unterwald EM; Tsukada H; Kakiuchi T; Kosugi T; Nishiyama S; Kreek MJ
    Brain Res; 1997 Nov; 775(1-2):183-8. PubMed ID: 9439841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
    Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
    Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects.
    Wang GJ; Volkow ND; Logan J; Fowler JS; Schlyer D; MacGregor RR; Hitzemann RJ; Gur RC; Wolf AP
    Life Sci; 1995; 56(14):PL249-53. PubMed ID: 7475891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography.
    Tsukada H; Kreuter J; Maggos CE; Unterwald EM; Kakiuchi T; Nishiyama S; Futatsubashi M; Kreek MJ
    J Neurosci; 1996 Dec; 16(23):7670-7. PubMed ID: 8922423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET.
    Rosa-Neto P; Doudet DJ; Cumming P
    Neuroimage; 2004 Jul; 22(3):1076-83. PubMed ID: 15219579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography (PET) study: the effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP, SUN 0588) on the central dopamine D1, D2 and D3 receptors in rhesus monkey.
    Tani Y; Ishihara T; Kanai T; Ohno T; Onoe H; Watanabe Y; Andersson J; Lilija A; Westerberg G; Hartvig P
    Adv Exp Med Biol; 1993; 338():327-30. PubMed ID: 8304130
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of cerebral ischemia on dopamine receptors in the gerbil striatum.
    Araki T; Kato H; Shuto K; Fujiwara T; Kogure K; Itoyama Y
    Eur J Pharmacol; 1996 Jun; 306(1-3):73-9. PubMed ID: 8813617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.
    Nordström AL; Farde L; Nyberg S; Karlsson P; Halldin C; Sedvall G
    Am J Psychiatry; 1995 Oct; 152(10):1444-9. PubMed ID: 7573582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors.
    Yang ZY; Perry B; Mukherjee J
    Nucl Med Biol; 1996 Aug; 23(6):793-805. PubMed ID: 8940723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained withdrawal allows normalization of in vivo [11C]N-methylspiperone dopamine D2 receptor binding after chronic binge cocaine: a positron emission tomography study in rats.
    Maggos CE; Tsukada H; Kakiuchi T; Nishiyama S; Myers JE; Kreuter J; Schlussman SD; Unterwald EM; Ho A; Kreek MJ
    Neuropsychopharmacology; 1998 Aug; 19(2):146-53. PubMed ID: 9629568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
    Thomas WS; Neal-Beliveau BS; Joyce JN
    Brain Res Dev Brain Res; 1998 Nov; 111(1):99-106. PubMed ID: 9804909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.
    Reader TA; Molina-Holgado E; Dewar KM
    Mol Neurobiol; 1992; 6(4):425-50. PubMed ID: 1285933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Age-related decrease of 11C-N-methylspiperone in vivo binding to human striatum detected by PET].
    Iyo M; Yamasaki T; Fukuda H; Inoue O; Suzuki K; Shinotoh H; Ito T; Yonezawa H; Nishio M; Koseki A
    Kaku Igaku; 1989 Feb; 26(2):213-20. PubMed ID: 2525202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone.
    Nyberg S; Farde L; Eriksson L; Halldin C; Eriksson B
    Psychopharmacology (Berl); 1993; 110(3):265-72. PubMed ID: 7530376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related changes in human D1 dopamine receptors measured by positron emission tomography.
    Suhara T; Fukuda H; Inoue O; Itoh T; Suzuki K; Yamasaki T; Tateno Y
    Psychopharmacology (Berl); 1991; 103(1):41-5. PubMed ID: 1826059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of N-alkylation on the affinities of analogues of spiperone for dopamine D2 and serotonin 5-HT2 receptors.
    Mach RH; Jackson JR; Luedtke RR; Ivins KJ; Molinoff PB; Ehrenkaufer RL
    J Med Chem; 1992 Feb; 35(3):423-30. PubMed ID: 1531364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal [11C]-N-methyl-spiperone binding in patients with focal dystonia (torticollis) using positron emission tomography.
    Leenders K; Hartvig P; Forsgren L; Holmgren G; Almay B; Eckernäs SA; Lundqvist H; Långström B
    J Neural Transm Park Dis Dement Sect; 1993; 5(2):79-87. PubMed ID: 8101445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
    Rosa-Neto P; Gjedde A; Olsen AK; Jensen SB; Munk OL; Watanabe H; Cumming P
    Synapse; 2004 Sep; 53(4):222-33. PubMed ID: 15266554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntington's disease progression. PET and clinical observations.
    Andrews TC; Weeks RA; Turjanski N; Gunn RN; Watkins LH; Sahakian B; Hodges JR; Rosser AE; Wood NW; Brooks DJ
    Brain; 1999 Dec; 122 ( Pt 12)():2353-63. PubMed ID: 10581228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.